» Articles » PMID: 24012335

Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2013 Sep 10
PMID 24012335
Citations 315
Authors
Affiliations
Soon will be listed here.
Abstract

Although Merlin/NF2 was discovered two decades ago as a tumor suppressor underlying Neurofibromatosis type II, its precise molecular mechanism remains poorly understood. Recent studies in Drosophila revealed a potential link between Merlin and the Hippo pathway by placing Merlin genetically upstream of the kinase Hpo/Mst. In contrast to the commonly depicted linear model of Merlin functioning through Hpo/Mst, here we show that in both Drosophila and mammals, Merlin promotes downstream Hippo signaling without activating the intrinsic kinase activity of Hpo/Mst. Instead, Merlin directly binds and recruits the effector kinase Wts/Lats to the plasma membrane. Membrane recruitment, in turn, promotes Wts phosphorylation by the Hpo-Sav kinase complex. We further show that disruption of the actin cytoskeleton promotes Merlin-Wts interactions, which implicates Merlin in actin-mediated regulation of Hippo signaling. Our findings elucidate an important molecular function of Merlin and highlight the plasma membrane as a critical subcellular compartment for Hippo signal transduction.

Citing Articles

Genome-wide screening in human embryonic stem cells identifies genes and pathways involved in the p53 pathway.

Haddad A, Golan-Lev T, Benvenisty N, Goldberg M Mol Med. 2025; 31(1):97.

PMID: 40082762 PMC: 11907909. DOI: 10.1186/s10020-025-01141-5.


Gracillin suppresses cancer progression through inducing Merlin/LATS protein-protein interaction and activating Hippo signaling pathway.

Su J, Zhou H, Zhang Z, Zhou X, Zou Q, Li S Acta Pharmacol Sin. 2025; .

PMID: 40055528 DOI: 10.1038/s41401-025-01514-w.


The evolving landscape of NF gene therapy: Hurdles and opportunities.

ODonohue A, Ginn S, Burgio G, Berman Y, Dabscheck G, Schindeler A Mol Ther Nucleic Acids. 2025; 36(1):102475.

PMID: 40034205 PMC: 11872496. DOI: 10.1016/j.omtn.2025.102475.


Portrait of WWP1: the current state in human cancer.

Lei J, Chen J, Yu W, Wu Q, Jing S, Tang Y Front Cell Dev Biol. 2025; 12:1516613.

PMID: 39949609 PMC: 11821962. DOI: 10.3389/fcell.2024.1516613.


The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response.

Chen H, Xu Y, Chen D, Xiao D, Yang B, Wang W BMC Cancer. 2025; 25(1):223.

PMID: 39920630 PMC: 11806854. DOI: 10.1186/s12885-025-13661-8.


References
1.
Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C . The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol. 2005; 8(1):27-36. DOI: 10.1038/ncb1339. View

2.
Trofatter J, MacCollin M, Rutter J, Murrell J, Duyao M, Parry D . A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993; 72(5):791-800. DOI: 10.1016/0092-8674(93)90406-g. View

3.
Struhl G, Adachi A . Nuclear access and action of notch in vivo. Cell. 1998; 93(4):649-60. DOI: 10.1016/s0092-8674(00)81193-9. View

4.
Wada K, Itoga K, Okano T, Yonemura S, Sasaki H . Hippo pathway regulation by cell morphology and stress fibers. Development. 2011; 138(18):3907-14. DOI: 10.1242/dev.070987. View

5.
Metpally R, Sowdhamini R . Cross genome phylogenetic analysis of human and Drosophila G protein-coupled receptors: application to functional annotation of orphan receptors. BMC Genomics. 2005; 6:106. PMC: 1192796. DOI: 10.1186/1471-2164-6-106. View